Prospects for mTOR-mediated functional repair after central nervous system trauma

Neurobiology of Disease

Volumn 85, Issue , 2016, Pages 99-110

  Berry, Martin ^a   Ahmed, Zubair ^a   Morgan Warren, Peter ^a   Fulton, Daniel ^a   Logan, Ann ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Axogenesis; Axon regeneration; MTOR; Myelination; Spinal cord injury

Indexed keywords

APC PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; COFILIN; DDIT4; FIBROBLAST GROWTH FACTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; OSTEOPONTIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN NOGO; PROTEIN P75; RAPAMYCIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SEMAPHORIN 3A; SHORT HAIRPIN RNA; SIRTP801; UNCLASSIFIED DRUG; TARGET OF RAPAMYCIN KINASE;

AGE RELATED MACULAR DEGENERATION; CELL SURVIVAL; ENTROPY; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL CNS INJURY; GENE SILENCING; HYPERACTIVITY; INNATE IMMUNITY; MYELINATION; NEOPLASM; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REINNERVATION; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; SYNAPTOGENESIS; ANIMAL; AXON; HUMAN; METABOLISM; NERVE REGENERATION; PATHOPHYSIOLOGY; PHYSIOLOGY; TRAUMA, NERVOUS SYSTEM;

ANIMALS; AXONS; HUMANS; NERVE REGENERATION; TOR SERINE-THREONINE KINASES; TRAUMA, NERVOUS SYSTEM;

EID: 84945936988     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2015.10.002     Document Type: Review

References (197)

1. Abe N., Borson S.H., Gambello M.J., Wang F., Cavalli V. Mammalian target of rapamycin (mTOR) activation increases axonal growth capacity of injured peripheral nerves. J. Biol. Chem. 2010, 285:28034-28043.
2. Ahmed B.Y., Chakravarthy S., Eggers R., Hermens W.T.J.M.C., Zang J.Y., Niclou S.P., Levelt C., Sablitzky F., Anderson P.N., Liberman A.R., Verhaagen J. Efficient delivery of Cre-recombinase to neurons in vivo and stable transduction of neurons using adeno-associated and lentiviral vectors. BMC Neurosci. 2004, 5:4.
3. Ahmed Z., Dent R.G., Suggate E.L., Barrett L.B., Seabright R.J., Berry M., Logan A. Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A. Mol. Cell. Neurosci. 2005, 28:509-523.
4. Ahmed Z., Suggate E.L., Brown E.R., Dent R.G., Armstrong S.J., Barrett L.B., Berry M., Logan A. Schwann cell-derived factor-induced modulation of the NgR/p75NTR/EGFR axis disinhibits axon growth through CNS myelin in vivo and in vitro. Brain 2006, 129:1517-1533.
5. Ahmed Z., Berry M., Logan A. ROCK inhibition promotes adult retinal ganglion cell neurite outgrowth only in the presence of growth promoting factors. Mol. Cell. Neurosci. 2009, 42:128-133.
6. Ahmed Z., Kalinski H., Berry M., Almasieh M., Ashush H., Slager N., Brafman A., Spivak I., Prasad N., Mett I., Shalom E., Alpert E., Di Polo A., Feinstein E., Logan A. Ocular neuroprotection by siRNA targeting caspase-2. Cell Death Dis. 2011, 2:e173. 10.1038/cddis.2011.54.
7. Alabed Y.Z., Pool M., Ong Tone S., Sutherland C., Fournier A.E. GSK3 beta regulates myelin-dependent axon outgrowth inhibition through CRMP4. J. Neurosci. 2010, 30:5635-5643.
8. Alayev A., Holz M.K. mTOR signalling for biological control and cancer. J. Cell. Physiol. 2013, 228:1658-1664.
9. Ali I.U., Schrim L.M., Dean M. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. J. Natl. Cancer Inst. 1999, 91:1922-1932.
10. Arevalo M.A., Rodriguez-Tébar A. Activation of casein kinase II and inhibition of phosphatase and tensin homologue deleted on chromosome 10 phosphatase by nerve growth factor/p75NTR inhibit glycogen synthase kinase-3 beta and stimulate axonal growth. Mol. Biol. Cell 2006, 17:3369-3377.
11. Arlotta P., Molyneaux B.J., Chen J., Inoue J., Kominami R., Macklis J.D. Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron 2005, 45:207-221.
12. Aruni S., Don A., Tsang C.K., Kazdoba T.M., D'Arcangelo G., Young W., XFS Z. Targeting mTOR as a novel therapeutic strategy for traumatic CNS injury. Drug Discov. Today 2012, 17:861-868.
13. Aschauer D.F., Kreuz S., Rumpel S. Analysis of transduction efficiency, tropism and axonal transport of AAV serotypes 1, 2, 5, 6, 8 and 9 in the mouse brain. PLoS One 2013, 8. 10.1371/journal.pone.0076310.eCollection 2013.
14. Azim K., Butt A.M. GSK3β negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 2011, 59:540-553.
15. Bähr M. Live or let die - retinal ganglion cell death and survival during development and in lesioned CNS. Trends Neurosci. 2000, 23:483-490.
16. Barros C.S., Nguyen T., Spencer K.S., Nishiyama A., Colognato H., Müller U. Beta1 integrins are required for normal CNS myelination and promote AKT-dependent myelin outgrowth. Development 2009, 136:2717-2724.
17. Bartzokis G. Neuroglial pharmacology: myelination as a shared mechanism of action of psychotropic treatments. J. Neuropharmacol. 2012, 62:2137-2153.
18. Bercury K.K., Dai J., Sachs H.H., Ahrendsen J.T., Wood T.L., Macklin W.B. Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. J. Neurosci. 2014, 34:4466-4480.
19. Berkelaar M., Clarke D.B., Wang Y.C., Bray G.M., Aguayo A.J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 1994, 14:4368-4374.
20. Berry M., Carlisle J., Hunter A. Peripheral nerve implants grafted into the vitreous body of the eye promote the regeneration of retinal ganglion cell axons severed in the optic nerve. J. Neurocytol. 1996, 25:147-170.
21. Berry M., Carlile J., Hunter A., Tsang W., Rosenstiel P., Sievers J. Optic nerve regeneration after intravitreal peripheral nerve implants: trajectories of axons regrowing through the optic chiasm into the optic tracts. J. Neurocytol. 1999, 28:721-741.
22. Berry M., Ahmed Z., Lorber B., Douglas M., Logan A. Regeneration of axons in the visual system. Restor. Neurol. Neurosci. 2008, 26:147-174.
23. Brown T.M., Gias C., Hatori M., Keding S.R., Semo M., Coffey P.J., Gigg J., Piggins H.D., Panda S., Lucas R.J. Melanopsin contributions to irradiance coding in the thalamo-cortical visual system. PLoS Biol. 2010, 8. 10.1371/journal.pbio.1000558.
24. Bruce C.C., Zhao C., Franklin R.J. Remyelination - an effective means of neuroprotection. Horm. Behav. 2010, 57:56-62.
25. Cai D., Qiu J., Cao Z., McAtee M., Bregman B.S., Filbin M.T. Neuronal cyclic AMP controls the developmental loss in ability of axons to regenerate. J. Neurosci. 2001, 21:4731-4739.
26. Cargnello M., Tcherkezian J., Roux P.P. The expanding role of mTOR in cancer cell growth and proliferation. Mutagenesis 2015, 30:169-176.
27. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993, 10:729-740.
28. Cellerino A., Bähr M., Isenmann S. Apoptosis in the developing visual system. Cell Tissue Res. 2000, 301:53-69.
29. Chari D.M. Remyelination in multiple sclerosis. Int. Rev. Neurobiol. 2007, 79:589-620.
30. Chen H.-C., Fong T.-H., Hsu P.-W., Chiu W.-T.C. Multifaceted effects of rapamycin on functional recovery after spinal injury in rats through autophagy promotion, anti-inflammation, and neuroprotection. J. Surg. Res. 2013, 179:E203-E210.
31. Chidlow G., Wood J.P., Manavis J., Osborne N.N., Casson R.J. Expression of osteopontin in the rat retina: effects of excitotoxic and ischemic injuries. Invest. Ophthalmol. Vis. Sci. 2008, 49:762-771.
32. Chin P.C., Majdzadeh N., D'Mello S.R. Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res. Mol. Brain Res. 2005, 137:193-201.
33. Chong Z.Z., Li F., Maiese K. The pro-survival pathways of mTOR and protein kinase B target glycogen synthase kinase-3beta and nuclear factor-kappaB to foster endogenous microglial cell protection. Int. J. Mol. Med. 2007, 19:263-272.
34. Christie K.J., Webber C.A., Martinez J.A., Singh B., Zochodne D.W. PTEN inhibition to facilitate intrinsic regenerative outgrowth of adult peripheral axons. J. Neurosci. 2010, 30:9306-9315.
35. Codeluppi S., Svensson C.I., Hefferan M.P., Valencia F., Silldorf M.D., Oshiro M., Marsala M., Pasquagale E.B. The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord. J. Neurosci. 2009, 29:1093-1104.
36. Codeluppi S., Fernandez-Zafra T., Sandor K., Kjell J., Liu Q., Abrams M., Olson L., Gray N.S., Svensson C.I., Uhlen P. Interleukin-6 secretion by astrocytes is dynamically regulated by PI3K-mTOR-calcium signalling. PLoS One 2014, 9:1-15.
37. Crawford A.H., Stockley J.H., Tripathi R.B., Richardson W.D., Franklin R.J.M. Oligodendrocyte progenitors: adult stem cells of the central nervous system?. Exp. Neurol. 2014, 260:50-55.
38. Crino P.B., Nathanson K.L., Henske E.P. The tuberous sclerosis complex. N. Engl. J. Med. 2006, 355:1345-1356.
39. Cui Q., Ren C., Sollars P.J., Pickard G.E., So K.-F. The injury resistant ability of melanopsin-expressing intrinsically photosensitive retinal ganglion cells. Neuroscience 2015, 285:845-853.
40. Dai J., Bercury K.K., Macklin W.B. Interaction of mTOR and Erk1/2 signalling to regulate oligodendrocyte differentiation. Glia 2014, 62:2096-2109.
41. De Lima S., Koriyama Y., Kurimoto T., Oliviera J.T., Yin Y., Li Y., Gilbert H.Y., Gagiolini M., Martinez A.M., Benowitz L. Full length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviours. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:9149-9154.
42. De Lima S., Habboub G., Benowitz L.I. Combinatorial therapy stimulates long-distance regeneration, target reinnervation, and partial recovery of vision after optic nerve injury in mice. Int. Rev. Neurobiol. 2012, 106:153-172.
43. De Paula M.L., Cui Q.L., Hossain S., Antel J., Almazan G. The PTEN inhibitor bisperoxovanadium enhances myelination by amplifying IGF-1 signalling in rat and human oligodendrocyte progenitors. Glia 2014, 62:64-67.
44. Del Río P., Irmler M., Arango-González B., Favor J., Bobe C., Bartsch U., Vecino E., Beckers J., Hauck S.M., Ueffing M. GDNF-induced osteopontin from Müller glial cells promotes photoreceptor survival in the Pde6brd1 mouse model of retinal degeneration. Glia 2011, 59:821-832.
45. Dent E.W., Gertler F.B. Cytoskeletal dynamics and transport in growth cone motility and axon guidance. Neuron 2003, 40:209-227.
46. Di Polo A. Dendritic pathology and neurodegeneration: focus on mTOR. Neural Regen. Res. 2015, 10:559-561.
47. Dibble C.C., Cantley L.C. Regulation of mTORC1 by PI3K signalling. Trends Cell Biol. 2015, 10.1016/j.tcb.2015.06.002.
48. Diekmann H., Leibinger M., Fischer D. Do growth-stimulated retinal ganglion cell axons find their central targets after optic nerve injury? New insights by three-dimensional imaging of the visual pathway. Exp. Neurol. 2013, 248:254-257.
49. Dill J., Wang H., Zhou F., Li S. Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J. Neurosci. 2008, 26:8914-8928.
50. Don A.S., Zheng Z.F. Recent clinical trials of mTOR-targeted cancer therapies. Rev. Recent Clin. Trials 2011, 6:24-34.
51. Don A.S., Tsang C.K., Kazdoba T.M., D'Arcangelo G., Young W., Zheng X.F. Targeting mTOR as a novel therapeutic for traumatic CNS injury. Drug Discov. Today 2012, 17:861-868.
52. Doring A., Yong V.W. The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair. Front. Biosci. (Schol. Ed.) 2011, 3:846-856.
53. Douglas M.R., Morrison K.C., Jacques S.J., Leadbeater W.E., Gonzalez A.M., Berry M., Logan A., Ahmed Z. Off-target effects of epidermal growth factor receptor antagonists mediate retinal ganglion cell disinhibited axon growth. Brain 2009, 132:3102-3121.
54. Du K., Zheng S., Zhang Q., Li S., Gao X., Wang J., Jiang L., Liu K. Pten deletion promotes regrowth of corticospinal tract axons 1year after spinal cord injury. J. Neurosci. 2015, 35:9754-9763.
55. Duan X., Qiao M., Bei F., Kim I.J., He Z., Sanes J.R. Subtype-specific regeneration of retinal ganglion cells following axotomy: effects of osteopontin and mTOR signaling. Neuron 2015, 10.1016/j.neuron.2015.02.017.
56. Dunlop E.A., Tee A.R. mTOR and autophagy: a dynamic relationship governed by nutrients and energy. Semin. Cell Dev. Biol. 2014, 36:121-129.
57. Duzgun Z., Eroglu Z., Avci C.B. Role mTOR in glioblastoma. Gene 2015, (15):01058-6. (pii: S0378-1119). 10.1016/j.gene.2015.08.060.
58. Ebrahimi-Fakhari D., Sahin M. Autism and the synapse: emerging mechanisms and mechanism-based therapies. Curr. Opin. Neurol. 2015, (PMID 25695134).
59. Ecker J.L., Dumitrescu O.N., Wong K.Y., Alam N.M., Chen S.K., LeGates T., Renna J.M., Prusky G.T., Berson D.M., Hattar S. Melanopsin-expressing retinal ganglion-cell photoreceptors: cellular diversity and role in pattern vision. Neuron 2010, 67:49-60.
60. Eickholt B.J., Walsh F.S., Doherty P. An inactive pool of GSK-3 at the leading edge of growth cones is implicated in Semaphorin 3A signaling. J. Cell Biol. 2002, 157:211-217.
61. Estevez M.E., Fogerson P.M., Llardi M.C., Borghuis B.G., Chan E., Weng S., Auferkorte O.N., Demb J.B., Berson D.M. Form and function of the M4 cell, an intrinsically photosensitive retinal ganglion cell type contributing to geniculocortical vision. J. Neurosci. 2012, 32:13608-13620.
62. Fields R.D. White matter in learning, cognition and psychiatric disorders. Trends Neurosci. 2008, 31:361-370.
63. Fischer D. What are the principal mediators of optic nerve regeneration after inflammatory stimulation in the eye?. Proc. Natl. Acad. Sci. U. S. A. 2010, 107. 10.1073/pnas.0912942107.
64. Fischer D., Leibinger M. Promoting optic nerve regeneration. Prog. Retin. Eye Res. 2012, 31:688-701.
65. Flores A.J., Mallon B.S., Matsui T., Ogawa Rosenzveig A., Okamoto T., Macklin W.B. Akt-mediated survival of oligodendrocytes induced by neuregulins. J. Neurosci. 2000, 20:7622-7630.
66. Flores A.I., Narayanan S.P., Morse E.N., Shick H.E., Yin X., Kidd G., Avila R.L., Kirschner D.A., Macklin W.B. Constitutively active Akt induces enhanced myelination in the CNS. J. Neurosci. 2008, 28:7174-7183.
67. Fonseca B.D., Smith E.M., Yelle N., Alain T., Bushell M., Pause A. The ever-evolving role of mTOR in translation. Semin. Cell Dev. Biol. 2014, 10.1016/j.semcdb.2014.09.014.
68. Franklin R.J., ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 2008, 9:839-855.
69. Franklin R.J., ffrench-Constant C., Edgar J.M., Smith K.J. Neuroprotection and repair in multiple sclerosis. Nat. Rev. Neurol. 2012, 8:624-634.
70. Franklin R.J., Kotter M.R. The biology of CNS remyelination: the key to therapeutic advances. J. Neurol. 2008, 255(Suppl. 1):19-25.
71. Fraser M.M., Zhu X., Kwon C.-H., Uhlmann E.J., Glutmann D.H., Baker S.J. Pten loss causes hypertrophy and increased proliferation of astrocytes in vivo. Cancer Res. 2004, 64:7773-7779.
72. Freude S., Leeser U., Müller M., Hettich M.M., Udelhoven M., Schilbach K., Tobe K., Kadowaki T., Köhler C., Schröder H., Krone W., Brüning J.C., Schubert M. IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination. J. Neurochem. 2008, 107:907-917.
73. Fukata Y., Itoh T.J., Kimura T., Ménager C., Nishimura T., Shiromizu T., Watanabe H., Inagaki N., Iwamatsu A., Hotani H., Kaibuchi K. CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 2002, 4:583-591.
74. Galvao R.P., Kasina A., McNeil R.S., Harbin J.E., Foreman O., Verhaak R.G.W., Nishiyama A., Miller C.R., Zong H. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactive process. Proc. Natl. Acad. Sci. U. S. A. 2014, 111:E4214-E4223. 10.1073/pnas. 414389111.
75. Garcia-Junco-Clemente P., Golshani P. PTEN: a master regulator of neuronal structure, function, and plasticity. Commun. Integr. Biol. 2014, 7. 10.4161/cib.28358.
76. Geoffroy C.G., Zheng B. Myelin-associated inhibitors in axonal growth after CNS injury. Curr. Opin. Neurobiol. 2014, 27:31-38.
77. Geoffroy C.G., Lorenzana A.O., Kwan J.P., Lin K., Ghassemi O., Ma A., Xu N., Creger D., Liu K., He Z., Zheng B. Effects of PTEN and Nogo codeletion on corticospinal axon sprouting and regeneration in mice. J. Neurosci. 2015, 35:6413-6428.
78. Gholizadeh S., Tharmalingam S., MacAldaz M.E., Hampson D.R. Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice. Hum. Gene Ther. Methods 2013, 24:205-213.
79. Gobrecht P., Leibinger M., Andreadaki A., Fischer D. Sustained GSK3 activity markedly facilitates nerve regeneration. Nat. Commun. 2014, 5. 10.1038/ncomms5561190.
80. Goebbles S., Oltrogge J.H., Kemper R., Heilmann I., Bormuth I., Wolfer S., Wickert S.P., Möbius W., Liu X., Lappe-Seifke C., Rossner M.J., Groszer M., Suter U., Frahm J., Boretius S., Nave K.-A. Elevated phosphatidylinositol 3,4,5-triphosphate in glia triggers cell-autonomous membrane wrapping and myelination. J. Neurosci. 2010, 30:8953-8964.
81. Goold R.G., Gordon-Weeks P.R. Glycogen synthase kinase 3β and the regulation of axon growth. Biochem. Soc. Trans. 2004, 32:809-811.
82. Guzman-Aranguez A., Loma P., Pintor J. Small interfering RNAs (siRNAs) as a promising tool for ocular therapy. Br. J. Pharmacol. 2013, 170:730-747.
83. Hanada M., Feng J., Hemmings B.A. Structure, regulation and function of PKB/AKT-a major therapeutic target. Biochim Biophys Acta (BBA)-Proteins Proteomics 2004, 1697:3-16.
84. Harvey A.R., Kamphuis W., Eggers R., Symons N.A., Blits B., Niclou S., Boer G.J., Verhaagen J. Intravitreal injection of adeno-associated viral vectors results in the transduction of different types of retinal neurons in neonatal and adult rats: a comparison with lentiviral vectors. Mol. Cell. Neurosci. 2002, 21:141-157.
85. Harvey A.R., Ooi J.W.W., Rodger J. Neurotrophic factors and the regeneration of adult retinal ganglion cell axons. Int. Rev. Neurobiol. 2012, 106:1-33.
86. Hattar S., Kumar M., Park A., Tong P., Tung J., Yau K.W., Berson D.M. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J. Comp. Neurol. 2006, 497:326-349.
87. Haws M.E., Jaramillo T.C., Espinosa F., Widman A.J., Stuber G.D., Sparta D.R., Tye K.M., Russo S.J., Parada L.F., Stavarache M., Kaplitt M., Bonci A., Powell C.M. PTEN knockdown alters dendritic spine/protrusion morphology, not density. J. Comp. Neurol. 2014, 522:1171-1190.
88. Hay N. The Akt/mTOR tango and its relevance to cancer. Cancer Cell 2005, 8:179-183.
89. He Z. Intrinsic control of axon growth. J. Biomed. Res. 2010, 24:2-5.
90. Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem. J. 2003, 374:1-20.
91. Heras-Sandoval D., Pérez-Rojas J.M., Hernández-Damián J., Pedraza-Chaverri J. The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration. Cell. Signal. 2014, 26:2694-2701.
92. Hoeffer C.A., Klann E. mTOR signalling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 2009, 10.1016/j.tins.2009.11.003.
93. Hur E.M., Zhou F.Q. GSK3 signalling in neural development. Nat Rev Neurosci. 2010, 11:539-551.
94. Ichikawa M., Yoshida J., Saito K., Sagawa H., Tokita Y., Watanabe M. Differential effects of two ROCK inhibitors, Fasudil and Y-27632, on optic nerve regeneration in adult cats. Brain Res. 2008, 1201:23-33.
95. Inoki K., Corradetti M.N., Guan K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 2005, 37:19-24.
96. Ito Y., Oinuma I., Katoh H., Kaibuchi K., Negishi M. Seama4D/plexin-B1 activates GSK-3beta through R-Ras Gap activity, inducing growth cone collapse. EMBO Rep. 2006, 7:704-709.
97. Jasmin L., Ohara P.T. Remyelination within the CNS: do Schwann cells pave the way for oligodendrocytes?. Neuroscientist 2002, 8:198-203.
98. Kanno H., Ozawa H., Sekiguchi A., Yamaya S., Tateda S., Yahata K., Itoi E. The role of mTOR signalling pathway in spinal cord injury. Cell Cycle 2012, 11:1175-1179.
99. Kermer P., Klöcker N., Labes M., Bähr M. Insulin-like growth factor-1 protects axotomised rat retinal ganglion cells from secondary death via PI3-K-dependent Akt phosphorylation and inhibition of caspase-3 in vivo. J. Neurosci. 2000, 20:722-728.
100. Kim W.Y., Zhou F.Q., Zhou J., Yokota Y., Wang Y.M., Yoshimura T., Kaibuchi K., Woodgett J.R., Anton E.S., Snider W.D. Essential roles for GSK-3β and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth. Neuron 2006, 52:981-996.
101. Koeberle P.D., Bähr M. Growth cone guidance cues for regenerating axons: where have they gone?. J. Neurobiol. 2004, 59:162-180.
102. Kumar S., Patel R., Moore S., Crawford D.K., Suwanna N., Mangiardi M., Tiwari-Woodruff S.K. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signalling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Neurobiol. Dis. 2013, 56:131-144.
103. Kurimoto T., Yin Y., Omura K., Gilbert H.Y., Kim D., Cen L.P., Moko L., Kügler S., Benowitz L.I. Long-distance axon regeneration in the mature optic nerve: contributions of oncomodulin, cAMP, and pten gene deletion. J. Neurosci. 2010, 30:15654-15663.
104. Lai W.S., Westohal K.G., Paterinii M., Olivier B., Pavlidis B., Karayiorgou M., Gogos J.A. Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16906-16911.
105. Laplante M., Sabatini D.M. mTOR signalling at a glance. J. Cell Sci. 2009, 122:3589-3594.
106. Latacz A., Russell J.A., Ocłon E., Zubel-łojek J., Pierzchała-Koziec K. mTOR pathway - novel modulator of astrocyte activity. Folia Biol. (Krakow) 2015, 63:95-105.
107. Lebrun-Julien F., Bachmann L., Normén C., Trötzmller M., Köfeler H., Regg M.A., Hall M.N., Suter U. Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination. J. Neurosci. 2014, 34:8432-8448.
108. Lee D.-H., Luo X., Yungher B.J., Bray E., Lee J.K., Park K.K. Mammalian target of Rapamycin's distinct roles and effectiveness in promoting compensatory axonal sprouting in the injured CNS. J. Neurosci. 2014, 34:15347-15355.
109. Leibinger M., Müller A., Andreadaki A., Hauk T.G., Kirsch M., Fischer D. Neuroprotective and axon growth-promoting effects following inflammatory stimulation on mature retinal ganglion cells in mice depend on ciliary neurotrophic factor and leukaemia inhibitory factor. J. Neurosci. 2009, 29:14334-14341.
110. Leibinger M., Andreadaki A., Fischer D. Role of mTOR in neuroprotection and axon regeneration after inflammatory stimulation. Neurobiol. Dis. 2012, 46:314-324.
111. Leon S., Yin Y., Nguyen J., Irwin N., Benowitz L.I. Lens injury stimulates axon regeneration in the mature rat optic nerve. J. Neurosci. 2000, 20:4615-4626.
112. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., Parsons R. PTEN, a putative tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
113. Li N., Lee B., Liu R.J., Banasr M., Dwyer J.M., Iwata M., Li X.Y., Aghajanian G., Duman R.S. mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 2010, 329:959-964.
114. Li S., He Q., Wang H., Tang X., Ho K.W., Gao X., Zhang Q., Shen Y., Cheung A., Wong F., Wong Y.H., Ip N., Jiang L., Yung W.H., Liu K. Injured adult retinal axons with Pten and Socs3 co-deletion reform active synapses with suprachiasmatic neurons. Neurobiol. Dis. 2014, 10.1016/j.nbd.2014.09.019.
115. Li C.Y., Li X., Liu S.F., Qu W.S., Wang W., Tian D.S. Inhibition of mTOR pathway restrains astrocyte proliferation, migration and production of inflammatory mediators after oxygen-glucose deprivation and reoxygenation. Neurochem. Int. 2015, 10.1016/j.neuint.2015.03.001.
116. Lingor P., Teusch N., Schwarz K., Mueller R., Mack H., Bähr M., Mueller B.K. Inhibition of Rho kinase (ROCK) increases neurite outgrowth on chondroitin sulphate proteoglycan in vitro and axonal regeneration in the adult optic nerve in vivo. J. Neurochem. 2007, 103:181-189.
117. Lingor P., Tönges L., Pieper N., Bermel C., Barski E., Planchamp V., Bähr M. ROCK inhibition and CNTF interact on intrinsic signalling pathways and differentially regulate survival and regeneration in retinal ganglion cells. Brain 2008, 131:250-263.
118. Liu B., Chen H., Johns T.G., Neufeld A.H. Epidermal growth factor receptor activation: an upstream signal for transition of quiescent astrocytes into reactive astrocytes after injury. J. Neurosci. 2006, 26:7532-7540.
119. Liu K., Lu Y., Lee J.K., Samara R., Willenberg R., Sears-Kraxberger I., Tedeschi A., Park K.K., Jin D., Cai B., Xu B., Connolly L., Steward O., Zheng B., He Z. PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci. 2010, 13:1075-1081.
120. Liu K., Tedeschi A., Park K.K., He Z. Neuronal intrinsic mechanisms of axon regeneration. Annu. Rev. Neurosci. 2011, 34:131-152.
121. Liu C.-M., Hur E.-M., Zhou F.-Q. Coordinating gene expression and axon assembly to control growth: potential role of GSK3 signaling. Front. Mol. Neurosci. 2012, 5:1-11.
122. Liu Y., Wang L., Long Z., Wu Y., Wan Q., Jiang J., Wang Z. Inhibiting PTEN protects hippocampal neurons against stretch injury by decreasing membrane translocation of AMPA receptor GluR subunit. PLoS One 2013, 8.
123. Liz M.A., Mar F.M., Santos T.E., Pimentel H.I., Marques A.M., Morgado M.M., Vieira S., Sousa V.F., Pemble H., Wittmann T., Sutherland C., Woodgett J.R., Sousa M.M. Neuronal deletion of GSK3β increases microtubule speed in the growth cone and enhances axon regeneration via CRMP-2 and independently of MAP1B and CLASP2. BMC Biol. 2014, 12:47. 10.1186/1741-7007-12-47.
124. Loonstra A., Vooijs M., Beverloo H.B., Allak B.A., van Drunen E., Kanaar R., Berns A., Jonkers J. Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9209-9214.
125. Lu Y., Belin S., He Z. Signalling regulations of neuronal regenerative ability. Curr. Opin. Neurobiol. 2014, 27:135-142.
126. Lu P., Wang Y., Graham L., McHale K., Gao M., Wu D., Brock J., Blesch A., Rosenzweig E.S., Havton L.A., Zheng B., Conner J.M., Marsala M., Tuszynski M.H. Long-distance growth and connectivity of neural stem cells after severe spinal cord injury. Cell 2014, 150:1264-1273.
127. Luo X., Salgueiro Y., Beckerman S.R., Lemmon V.P., Tsoulfas P., Park K.K. Three-dimensional evaluation of retinal ganglion cell axon regeneration and pathfinding in whole mouse tissue after injury. Exp. Neurol. 2013, 247:653-662.
128. Madisen L., Garner A.R., Shimaoka D., Chuong A.S., Klapoetke N.C., Li L., van der Bourg A., Niino Y., Egolf L., Monetti C., Gu H., Mills M., Cheng A., Tasic B., Nguyen T.N., Sunkin S.M., Benucci A., Nagy A., Miyawaki A., Helmchen F., Empson R.M., Knöpfel T., Boyden E.S., Reid R.C., Carandini M., Zeng H. Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance. Neuron 2015, 85:942-958.
129. Maiese K. Driving neural regeneration through the mammalian target of rapamycin. Neural Regen. Res. 2014, 9:1413-1417.
130. Maiese K., Chong Z.Z., Shang Y.C., Wang S. mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol. Med. 2013, 19:51-60.
131. Marcos S., Nieto-Lopez F., Sandonìs A., Cardozo M.J., Di Marco F., Esteve P., Bovolenta P. Secreted frizzled related proteins modulate pathfinding and fasciculation of mouse retina ganglion cell axons by direct and indirect mechanisms. J. Neurosci. 2015, 35:4729-4740.
132. Mead B., Logan A., Berry M., Leadbeater W., Scheven B.A. Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells. PLoS One 2014, 9. 10.1371/journal.pone.0109305.
133. Meijer L., Flajolet M., Greengard P. Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 2004, 25:471-480.
134. Miron V.E., Boyd A., Zhao J.W., Yuen T.J., Ruckh J.M., Shadrach J.L., van Wijngaarden P., Wagers A.J., Williams A., Franklin R.J., ffrench-Constant C. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 2013, 16:1211-1220.
135. Moore D.L., Blackmore M.G., Hu Y., Kaestner K.H., Bixby J.L., Lemmon V.P., Goldberg J.L. KLF gamily members regulate intrinsic axon regeneration ability. Science 2009, 326:298-301.
136. Moore S.M., Khalaj A.J., Kumar S., Winchester Z., Yoon J., Yoo T., Martinez-Torres L., Yasui N., Katzenellenbogen J.A., Tiwari-Woodruff S.K. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-C1 in a mouse model of multiple sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2014, 111. 10.1073/pnas14112911.
137. Morgan-Warren P., Berry M., Ahmed Z., Scott R.A.H., Logan A. Exploiting mTOR signalling: a novel translatable treatment for traumatic optic neuropathy. Invest. Ophthalmol. Vis. Sci. 2013, 54:6903-6916.
138. Morimoto T., Miyoshi T., Matsuda S., Tano Y., Fujikado T., Fukuda Y. Transcorneal electrical stimulation rescues axotomized retinal ganglion cells by activating endogenous retinal IGF-1 system. Invest. Ophthalmol. Vis. Sci. 2005, 46:2147-2155.
139. Morquette B., Morquette P., Agostinone J., Feinstein E., McKinney R.A., Kolta A., Di Polo A. REDD2-mediated inhibition of mTOR poromotes dendrite retraction induced by axonal injury. Cell Death Differ. 2014, 10.1038/cdd.2014.149.
140. Müller A., Hauk T.G., Fischer D. Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation. Brain 2007, 130:3308-3320.
141. Müller A., Hauk T.G., Leibinger M., Marienfeld R., Fischer D. Exogenous CNTF stimulates axon regeneration of retinal ganglion cells partially via endogenous CNTF. Mol. Cell. Neurosci. 2009, 41:233-246.
142. Nakamura N., Ramaswamy S., Vazquez F., Signoretti S., Loda M., Sellers W. Forkhead transcription factors are critical effectors of cell death and cell cycle arrest downstream of PTEN. Mol. Cell. Biol. 2000, 20:8969-8982.
143. Nakayama H., Bruneau S., Kochupurakkal N., Coma S., Briscoe D.M., Klagsbrun M. Regulation of mTOR signalling by semaphorin 3F-Neuropilin 2 interactions in vitro and in vivo. Sci. Rep. 2015, 5:11789. 10.1038/srep11789.
144. Narayanan S.P., Flores A.I., Wang F., Macklin W.B. Akt signals through the mammalian target of rapamycin, mTOR, pathway to regulate central nervous system myelination. J. Neurosci. 2009, 29:6860-6870.
145. Nicholson S.E., De Souza D., Fabri L.J., Corbin J., Willson T.A., Zhang J.G., Silva A., Asimakis M., Farley A., Nash A.D., Metcalf D., Hilton D.J., Nicola N.A., Baca M. Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6493-6498.
146. Nie D., Di Nardo A., Han J.M., Baharanyi H., Kramvis I., Huynh T., Dabora S., Codeluppi S., Pandolfi P.P., Pasquale E.B., Sahin M. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat. Neurosci. 2010, 13:163-172.
147. Normén C., Suter U. Akt/mTOR signalling in myelination. Biochem. Soc. Trans. 2013, 41:944-950.
148. O'Neil C. PI3-kinase/Akt/mTOR signalling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease. Exp. Gerontol. 2013, 48:647-653.
149. Park K., Luo J.M., Hisheh S., Harvey A.R., Cui Q. Cellular mechanisms associated with spontaneous and ciliary neurotrophic factor-cAMP-induced survival and axonal regeneration of adult retinal ganglion cells. J. Neurosci. 2004, 24:1086-10815.
150. Park K.K., Liu K., Hu Y., Smith P.D., Wang C., Cai B., Xu B., Connolly L., Kramvis I., Sahin M., He Z. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 2008, 322:963-966.
151. Park K.K., Liu K., Hu Y., Kanter J.L., He Z. PTEN/mTOR and axon regeneration. Exp. Neurol. 2010, 223:45-50.
152. Patel J.R., Klein R.S. Mediators of oligodendrocyte differentiation during remyelination. FEBS Lett. 2011, 585:3730-3737.
153. Peace A.G., Shewan D.A. New perspectives in cyclic AMP-mediated axon growth and guidance: the emerging epoch of Epac. Brain Res. Bull. 2011, 84:280-288.
154. Perdigolo A.L., Chaudhry N., Barnes G.N., Filbin M.T., Carter B.D. A novel role for PTEN in the inhibition of neurite outgrowth by myelin-associated glycoprotein in cortical neurons. Mol. Cell. Neurosci. 2011, 46:235-244.
155. Pernet V., Schwab M.E. Lost in the jungle: new hurdles for optic nerve axon regeneration. Trends Neurosci. 2014, 37:381-387.
156. Pernet V., Joly S., Jordi N., Dalkara D., Guzik-Kornacka A., Flannery J.G., Schwab M.E. Misguidance and modulation of axonal regeneration by Stat3 and Rho/ROCK signaling in the transparent optic nerve. Cell Death Dis. 2013, 4.
157. Pernet V., Joly S., Dalkara D., Jordi N., Schwarz O., Christ F., Schaffer D.V., Flannery J.G., Schwab M.E. Long-distance axonal regeneration induced by CNTF gene transfer is impaired by axonal misguidance in the injured adult optic nerve. Neurobiol. Dis. 2013, 51:202-213.
158. Peru R.L., Mandrycky N., Nait-Oumesmar B., Lu Q.R. Paving the axonal highway: from stem cells to myelin repair. Stem Cell Rev. 2008, 4:304-318.
159. Pfeifer A., Brandon E.P., Kootstra N., Gage F.H., Verma I.M. Delivery of the Cre recombinase by a self-deleting lentiviral vector: efficient gene targeting in vivo. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:11450-11455.
160. Rosivatz E., Matthews J.G., McDonald N.Q., Mulet X., Ho K.K., Lossi N., Schmid A.C., Mirabelli M., Pomeranz K.M., Erneux C., Lam E.W., Vilar R., Woscholski R. A small molecule inhibitor for phosphatase and tensin homologue deleted on chromosome 10 (PTEN). ACS Chem. Biol. 2006, 1:780-790.
161. Sachs H.H., Bercury K.K., Popescu D.C., Narayanan S.P., Macklin W.B. A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro 2014, 30. 10.1177/1759091414551955.
162. Saijilafu H.E.M., Liu C.M., Jiao Z., Xu W.L., Zhou F.Q. PI3K-GSK3 signalling regulates mammalian axon regeneration by inducing the expression of Smad1. Nat. Commun. 2013, 4:2690. 10.1038/ncomms3690.
163. Sandvig A., Berry M., Barrett L.B., Butt A., Logan A. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia 2004, 46:225-251.
164. Schmidt E.E., Taylor D.S., Prigge J.R., Barnett S., Capecchi M.R. Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:13702-13707.
165. Schmidt T.M., Do M.T., Dacey D., Lucas R., Hattar S., Matynia A. Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function. J. Neurosci. 2011, 31:16094-16101.
166. Schmidt T.M., Alam N.M., Chen K.P., Li W., Prusky G.T., Hattar S. A role for melanopsin in alpha retinal ganglion cells and contrast detection. Neuron 2014, 10.1016/j.neuron.2014.03.022.
167. Shen J.W., Yi X.X., Xiong N.X., Wang H.J., Duan X.V.V., Zhao H.Y. GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells. Neurosci. Lett. 2011, 505:165-170.
168. Shewan D., Dwivedy A., Anderson R., Holt C.E. Age-related changes under-lie switch in netrin-1 responsiveness as growth cones advance along visual pathway. Nat. Neurosci. 2002, 5:955-962.
169. Silver J., Miller J.H. Regeneration beyond the glia scar. Nat. Rev. Neurosci. 2004, 5:146-156.
170. Sofroniew M.V. Molecular dissection of reactive astrogliosis and glial scar formation. Trends Neurosci. 2009, 32:638-647.
171. Sosunov A.A., Wu X., Weiner H.L., Mikell C.B., Goodman R.R., Crino P.D., McKhann G.M. Tuberous sclerosis: a primary pathology of Astrocytes?. Epilepsia 2008, 49:53-62.
172. Sun F., Park S.B., Belin S., Wang D., Lu T., Chen G., Zhang K., Yeung C., Feng G., Yankner B.A., He Z. Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 2011, 480:372-375.
173. Thévenot E., Côté F., Colin P., He Y., Leblois H., Perricaudet M., Mallet J., Vodjdani G. Targeting conditional gene modification into the serotonin neurons of the dorsal raphe nucleus by viral delivery of the Cre recombinase. Mol. Cell. Neurosci. 2003, 24:139-147.
174. Thoenen H., Sendtner M. Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat. Neurosci. 2002, 5:1046-1050. (Suppl).
175. Tsang C.K., Qi H., Liu L.F., Sheng X.F.S. Targeting mammalian target of Rapamycin (mTOR) for health and diseases. Drug Discov. Today 2007, 12:113-124.
176. Tyler W.A., Gangoli N., Gokina P., Kim H.A., Covey M., Levison S.W., Wood T.L. Activation of mammalian target of rapamycin (mTOR) is essential for oligodendrocyte differentiation. J. Neurosci. 2009, 29:6367-6378.
177. Uchida Y., Ohshima T., Sasaki Y., Suzuki H., Yanai S., Yamashita N., Nakamura F., Takei K., Ihara Y., Mikoshiba K., Kolattukudy P., Honnorat J., Goshima Y. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells 2005, 10:165-179.
178. Uhlmann E.J., Wong M., Baldwin R.L., Bajenaru M.L., Onda H., Kwiatkowski D.J., Yamada K., Gutmann D.H. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann. Neurol. 2002, 52:285-296.
179. Vigneswara V., Akpan N., Berry M., Logan A., Troy C.M., Ahmed Z. Combined suppression of CASP2 and CASP6 protects retinal ganglion cells from apoptosis and promotes axon regeneration through CNTF-mediated JAK/STAT signalling. Brain 2014, 137:1656-1675.
180. Wahl S.E., McLane L.E., Bercury K.K., Macklin W.B., Wood T.L. Mammalian target of rapamycin promotes oligodendrocyte differentiation, initiation and extent of myelination. J. Neurosci. 2014, 34:4453-4465.
181. Weidner N., Ner A., Salimi N., Tuszynski M.H. Spontaneous corticospinal axonal plasticity and functional recovery after adult central nervous system injury. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:3513-3518.
182. Williams M.R., DeSpenza T., Li M., Gulledge A.T., Luikart B.W. Hyperactivity of newborn Pten knock-out neurons results from increased excitatory synaptic drive. J. Neurosci. 2015, 35:943-959.
183. Wong M., Ess K.C., Uhlmann E.J., Jansen L.A., Li W., Crino P.B., Mennerick S., Yamada K.A., Gutmann D.H. Ann. Neurol. 2003, 54:251-256.
184. Wood T.L., Bercury K.K., Cifelli S.E., Mursch L.E., Min J., Dai J., Macklin W.B. mTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development. ASN Neuro 2013, 10.1042/AN20120092.
185. Wu D., Klaw M.C., Connors T., Kholodilov N., Burke R.E., Tom V.J. Expressing constitutively active Rheb in adult neurons after a complete spinal cord injury enhances axonal regeneration beyond a chondroitinase-treated glial scar. J. Neurosci. 2015, 35:11068-11080. 10.1523/JNEUROSCI.0719-15.2015.
186. Wullschleger S., Loewith R., Hall M.N. TOR signalling in growth and metabolism. Cell 2006, 124:471-484.
187. Yang Q., Guan K.-L. Expanding mTOR signalling. Cell Res. 2007, 17:666-681.
188. Yang P., Qin Y., Zhang W., Bian Z., Wang R. Sensorimotor cortex injection of adeno-associated viral vector mediates knockout of PTEN in neurons of the brain and spinal cord of mice. J. Mol. Neurosci. 2015, 10.1007/s1203.015-0610-x.
189. Yu M., Narayanan S.P., Wang F., Morse E., Macklin W.B., Peachey N.S. Visual abnormalities associated with enhanced optic nerve myelination. Brain Res. 2011, 1374:36-42.
190. Yungher B.J., Luo X., Salgueiro Y., Blackmore M.G., Park K.K. Viral vector based improvement of optic nerve regeneration: characterization of individual axons' growth patterns and synaptogenesis in a visual target. Gene Ther. 2015, 10.1038/gt.2015.51.
191. Zheng B., Ho C., Li S., Keirstead H., Steward O., Tessier-Lavigne M. Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron 2003, 38:213-224.
192. Zhou F.-Q., Snider W.D. GSK-3β and microtubular assembly in axons. Science 2005, 308:211-214.
193. Zhou F.Q., Zhou J., Dedhar S., Wu Y.H., Snider W.D. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 2004, 42:897-912.
194. Zou Y., Jiang W., Wang J., Li Z., Zhang J., Bu J., Zou J., Zhou L., Yu S., Cui Y., Yang W., Luo L., Lu Q.R., Liu Y., Chen M., Worley P.F., Xiao B. Oligodendrocyte precursor cell-intrinsic effect of Rheb1 controls differentiation and mediates mTOC1-dependent myelination in brain. J. Neurosci. 2014, 34:15764-15778.
195. Zou Y., Stagi M., Wang X., Yigitkanli K., Siegel C.S., Nakatsu F., Cafferty W.B., Stritttmatter S. Gene silencing screen for mammalian axon regeneration identifies Inpp5f (Sac2) as an endogenous suppressor of repair after spinal cord injury. J. Neurosci. 2015, 35:10429-10439.
196. Zukor K., Belin S., Wang C., Keelan N., Wang X., He Z. Short hairpin RNA against PTEN enhances regenerative growth of corticospinal tract axons after spinal cord injury. J. Neurosci. 2013, 33:15350-153651.
197. Zumbrunn J., Kinoshita K., Hyman A.A., Näthke I.S. Binding of the adenomatous polyposis coli protein to microtubules increases microtubule stability and is regulated by GSK3 beta phosphorylation. Curr. Biol. 2001, 11:44-49.